Exendin-4 directly improves endothelial dysfunction in isolated aortas from obese rats through the cAMP or AMPK-eNOS pathways

Diabetes Research and Clinical Practice
Lina HanBen Wang

Abstract

To determine whether exendin-4 might directly improve endothelial dysfunction in aorta isolated from high-fat diet-induced obese rats. Wistar rats were randomly divided into control and obesity (OB) groups and fed. Vascular segments of obese rats were incubated in organ bath in the presence or absence of exendin-4. Nitric oxide (NO) production and nuclear transcription factor kappa B expression in vascular rings were measured. The aortic rings of the obese rats were then incubated in an organ bath with exendin-4 in the presence or absence of the following inhibitors: the AMPK, the adenylate cyclase and the NO synthase inhibitor. The maximum endothelium-dependent vasodilatation (EDV) value was severely reduced in the OB group. Exendin-4 treatment significantly increased the NO level, improved endothelium-dependent vasodilatation and reduced expression of NF-κB in the obese group. The beneficial effect of exendin-4 on EDV in obese rats was partly attenuated in the presence of the specific inhibitors. Exendin-4 directly improves impaired EDV of aortae from obese rats. The beneficial effect of exendin-4 appears to be mediated in part via stimulation of cAMP/AMPK-related signalling pathways and enhancement of endothelial nitric oxid...Continue Reading

References

Feb 17, 2000·The Journal of Clinical Investigation·K CusiL J Mandarino
Feb 27, 2004·European Journal of Heart Failure·Andreas SchäferJohann Bauersachs
Sep 9, 2004·American Journal of Physiology. Endocrinology and Metabolism·Thomas NyströmAke Sjöholm
Jan 22, 2005·Journal of Hypertension·Hanspeter BrunnerUNKNOWN Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension
Mar 22, 2005·American Journal of Physiology. Heart and Circulatory Physiology·Amilton C SantosCarlos E Negrão
Jun 29, 2005·Clinica Chimica Acta; International Journal of Clinical Chemistry·Angelo Avogaro, Saula Vigili de Kreutzenberg
Aug 15, 2006·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Wenjuan S JobgenGuoyao Wu
Aug 23, 2007·American Journal of Physiology. Endocrinology and Metabolism·Ananda BasuMichael J Joyner
Jul 4, 2008·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Minoru SatohNaoki Kashihara
Aug 19, 2008·Archives of Biochemistry and Biophysics·Brian D GreenDavid J Grieve
Apr 23, 2009·Diabetes, Obesity & Metabolism·R GentilellaC M Rotella
May 16, 2009·Nature Reviews. Endocrinology·Julie A Lovshin, Daniel J Drucker
Jun 30, 2009·Peptides·Kristopher C DozierGregory P Victorino
Oct 14, 2009·International Journal of Obesity : Journal of the International Association for the Study of Obesity·G DengM-R Li
Dec 19, 2009·Trends in Endocrinology and Metabolism : TEM·Eva Tomas, Joel F Habener
Jan 6, 2011·Diabetes, Obesity & Metabolism·P AnagnostisD P Mikhailidis
Oct 1, 2011·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·A P DavelL V Rossoni

❮ Previous
Next ❯

Citations

Jan 17, 2014·Cardiovascular Diabetology·Jun-Ichi OyamaKoichi Node
Mar 8, 2014·Endocrine·Baptist Gallwitz
Aug 12, 2014·Journal of Endocrinological Investigation·G MuscogiuriA Colao
Oct 27, 2015·Naunyn-Schmiedeberg's Archives of Pharmacology·Uma JyotiSandeep Goyal
Nov 1, 2015·Biochemical and Biophysical Research Communications·Yue ZhouJiangui He
Mar 18, 2013·Journal of Diabetes Investigation·Yutaka Seino, Daisuke Yabe
Apr 15, 2015·Vascular Pharmacology·C F García-PrietoM S Fernández-Alfonso
Feb 20, 2015·Pharmaceutical Biology·Zongguang HuiRujiang Li
Oct 8, 2013·Current Opinion in Pharmacology·Daisuke Yabe, Yutaka Seino
Apr 20, 2016·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Yean Chun LohMun Fei Yam
Jul 31, 2016·Journal of Translational Medicine·Francesco AndreozziFranco Folli
Jul 21, 2017·American Journal of Physiology. Renal Physiology·Scott C ThomsonPrabhleen Singh
Mar 10, 2020·Canadian Journal of Physiology and Pharmacology·Chris R TriggleMorley D Hollenberg
Aug 7, 2020·Clinical and Experimental Pharmacology & Physiology·Kai LiXiaodong Sun
Sep 10, 2017·American Journal of Physiology. Heart and Circulatory Physiology·Dante A SuffrediniPeter Q Eichacker
Jul 29, 2017·Journal of Biomedical Science·Arijit GhoshChristopher W K Lai
Aug 7, 2021·Frontiers in Pharmacology·Wout VerbeurePeter R van Dijk
Sep 4, 2021·The FEBS Journal·Michelle GuoQi N Cui

❮ Previous
Next ❯

Related Concepts

Related Feeds

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.